BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioCapital

  Elekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society Meeting

  AES Annual Meeting in Washington, DC, Elekta announced that the new commercial name for its MEG business is MEGIN and also introduced its latest-generation MEG platform for investigating human brain activity, TRIUX neo.

  December 1, 2017

   · 

  3 min read
• Business

  Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer

  Dr Heinonen joins Faron from AstraZeneca where he served as the Global Marketing Director for AstraZeneca/Medimmune’s Fasenra (benralizumab), first biologic medication launched from AZ respiratory unit.

  December 1, 2017

   · 

  3 min read
• Business

  Employee Elected Board Member Change in Zealand Pharma – Dec. 1, 2017

  The company said Rasmus Just, Director of Business Development and employee-elected Board Member, leaves the company effective from 1 December 2017.

  December 1, 2017

   · 

  1 min read
• Veloxis Increases Share Capital in Connection With Exercise of Warrants - Dec. 1, 2017

  As a result of the employee’s investment in the Company proceeds to Veloxis Pharmaceuticals A/S from the capital increase amounts to DKK 520,164.

  December 1, 2017

   · 

  1 min read
• Skyline Medical Announces the Completion of Private Placement for Gross Proceeds of $1,300,000

  The closing of the private placement occurred on November 28, 2017.

  December 1, 2017

   · 

  5 min read
• Pharm Country

  Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C to ACDF at Seven Years

  SECURE-C long-term data confirms earlier clinical outcomes and maintains superiority.

  December 1, 2017

   · 

  5 min read
• Genetown

  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec. 1, 2017

  The employees received, in the aggregate, options to purchase 29,090 shares of Sarepta’s common stock.

  December 1, 2017

   · 

  1 min read
• Biotech Beach

  Adamis Announces Presentation of Results of a Human Factors Study Conducted With Its Newly Approved Epinephrine Pre-filled Syringe at the AAAAI Joint Congress With the World Allergy Organization

  This premier annual educational event draws thousands of healthcare professionals including allergists, immunologists and other medical specialists.

  December 1, 2017

   · 

  3 min read
• Drug Development

  AIT Therapeutics Announces Publication of Its Phase II Trial in Bronchiolitis Patients in the Pediatric Pulmonology Journal

  The article, entitled Nitric Oxide Inhalations in Bronchiolitis: A Pilot, Randomized, Double-Blinded, Controlled Trial was published in the December 2017 issue of the peer-reviewed Pediatric Pulmonology journal.

  December 1, 2017

   · 

  5 min read
• Business

  Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure

  The nanotechnology platform is initially targeting a cure for human immunodeficiency virus (HIV) using specific small interfering RNA (siRNA) molecules.

  December 1, 2017

   · 

  2 min read